EcoDrugPlus

Inositol Polyphosphate-5-Phosphatase D

Ensembl ID : ENSLBEG00000025835
Gene Symbol: INPP5D
3 Cross references
215 Possible Orthologues:

Insulin Receptor

Ensembl ID : ENSLBEG00000006683
Gene Symbol: INSR
3 Cross references
212 Possible Orthologues:

Insulin Receptor B

Ensembl ID : ENSLBEG00000005467
Gene Symbol: INSRB
1 Cross references
212 Possible Orthologues:

Insulin-Like Growth Factor 1a Receptor

Ensembl ID : ENSLBEG00000011631
Gene Symbol: IGF1RA
1 Cross references
204 Possible Orthologues:

Integrin Alpha-4-Like

Ensembl ID : ENSLBEG00000016579
Gene Symbol: LOC110005909
2 Cross references
224 Possible Orthologues:

Integrin Alpha-5-Like

Ensembl ID : ENSLBEG00000027992
Gene Symbol: LOC110002066
3 Cross references
206 Possible Orthologues:

Integrin Alpha-V-Like

Ensembl ID : ENSLBEG00000009559
Gene Symbol: LOC109979073
3 Cross references
236 Possible Orthologues:

Integrin Alpha-V-Like

Ensembl ID : ENSLBEG00000023575
Gene Symbol: LOC109985144
3 Cross references
236 Possible Orthologues:

Integrin Beta-1-Like

Ensembl ID : ENSLBEG00000005790
Gene Symbol: LOC109981973
3 Cross references
213 Possible Orthologues:

Integrin Beta-3

Ensembl ID : ENSLBEG00000005244
Gene Symbol: LOC109996880
3 Cross references
194 Possible Orthologues:

Integrin Beta-3-Like

Ensembl ID : ENSLBEG00000005153
Gene Symbol: LOC109983117
3 Cross references
201 Possible Orthologues:

Integrin Subunit Alpha 4

Ensembl ID : ENSLBEG00000020808
Gene Symbol: ITGA4
3 Cross references
224 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).